Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blanke

Showing results (51-60 of 190) with videos related to

Pageof 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancerC J A Punt, C D Blanke, J Zhang, et al.
JAMA Network Open|June 2, 2020
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical TrialsJoseph M Unger, Charles D Blanke, Michael LeBlanc, et al.
Journal of Oncology Practice|September 16, 2017
Responding to Patient Requests for Hastened Death: Physician Aid in Dying and the Clinical OncologistRebecca A Spence, Charles D Blanke, Thomas J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignanciesMichael C Heinrich, Charles D Blanke, Brian J Druker, et al.
Prostaglandins & Other Lipid Mediators|March 26, 2005
A phase I study of 5-fluorouracil, leucovorin, and celecoxib in patients with incurable colorectal cancerCharles D Blanke, Nora C Mattek, Thomas G Deloughery, et al.
Oncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardiaJ Randolph Hecht, Charles D Blanke, Al B Benson, et al.
The Oncologist|January 13, 2006
Management of gastrointestinal stromal tumors in the imatinib era: selected case studiesRobert S Benjamin, Charles D Blanke, Jean-Yves Blay, et al.
JAMA Network Open|July 29, 2021
Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 PandemicJoseph M Unger, Hong Xiao, Michael LeBlanc, et al.
Current Oncology (Toronto, Ont.)|December 7, 2013
Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancerH Kennecke, L Chen, C D Blanke, et al.
Oncology (Williston Park, N.Y.)|March 17, 2009
Perioperative treatment of gastrointestinal stromal tumorsGustavo dos Santos Fernandes, Charles D Blanke, Daniela Freitas, et al.
Pageof 19

Showing results (51-60 of 190) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancerC J A Punt, C D Blanke, J Zhang, et al.
JAMA Network Open|June 2, 2020
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical TrialsJoseph M Unger, Charles D Blanke, Michael LeBlanc, et al.
Journal of Oncology Practice|September 16, 2017
Responding to Patient Requests for Hastened Death: Physician Aid in Dying and the Clinical OncologistRebecca A Spence, Charles D Blanke, Thomas J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignanciesMichael C Heinrich, Charles D Blanke, Brian J Druker, et al.
Prostaglandins & Other Lipid Mediators|March 26, 2005
A phase I study of 5-fluorouracil, leucovorin, and celecoxib in patients with incurable colorectal cancerCharles D Blanke, Nora C Mattek, Thomas G Deloughery, et al.
Oncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardiaJ Randolph Hecht, Charles D Blanke, Al B Benson, et al.
The Oncologist|January 13, 2006
Management of gastrointestinal stromal tumors in the imatinib era: selected case studiesRobert S Benjamin, Charles D Blanke, Jean-Yves Blay, et al.
JAMA Network Open|July 29, 2021
Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 PandemicJoseph M Unger, Hong Xiao, Michael LeBlanc, et al.
Current Oncology (Toronto, Ont.)|December 7, 2013
Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancerH Kennecke, L Chen, C D Blanke, et al.
Oncology (Williston Park, N.Y.)|March 17, 2009
Perioperative treatment of gastrointestinal stromal tumorsGustavo dos Santos Fernandes, Charles D Blanke, Daniela Freitas, et al.
Pageof 19